Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lung Cancer

Identifieur interne : 001382 ( Main/Exploration ); précédent : 001381; suivant : 001383

Lung Cancer

Auteurs :

Source :

RBID : ISTEX:FF252DE98D9599EA1F9CD4859BE5AF21F5D3CD0E

English descriptors


Url:
DOI: 10.1111/j.1440-1843.2012.02296.x


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Lung Cancer</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:FF252DE98D9599EA1F9CD4859BE5AF21F5D3CD0E</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1111/j.1440-1843.2012.02296.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-FM0G10WK-C/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002841</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002841</idno>
<idno type="wicri:Area/Istex/Curation">002841</idno>
<idno type="wicri:Area/Istex/Checkpoint">000391</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000391</idno>
<idno type="wicri:Area/Main/Merge">001383</idno>
<idno type="wicri:Area/Main/Curation">001382</idno>
<idno type="wicri:Area/Main/Exploration">001382</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main">Lung Cancer</title>
</analytic>
<monogr></monogr>
<series>
<title level="j" type="main">Respirology</title>
<title level="j" type="sub">Abstracts of the 17th Congress of the Asian Pacific Society of Respirology, 14‐16 December 2012, Hong Kong</title>
<title level="j" type="alt">RESPIROLOGY</title>
<idno type="ISSN">1323-7799</idno>
<idno type="eISSN">1440-1843</idno>
<imprint>
<biblScope unit="vol">17</biblScope>
<biblScope unit="issue">S2</biblScope>
<biblScope unit="page" from="80">80</biblScope>
<biblScope unit="page" to="100">100</biblScope>
<biblScope unit="page-count">21</biblScope>
<publisher>Blackwell Publishing Asia</publisher>
<pubPlace>Melbourne, Australia</pubPlace>
<date type="published" when="2012-12">2012-12</date>
</imprint>
<idno type="ISSN">1323-7799</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">1323-7799</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>2biomedical research center</term>
<term>2department</term>
<term>Acupuncture treatment</term>
<term>Acute exacerbation</term>
<term>Adam malik</term>
<term>Adenocarcinoma</term>
<term>Adenocarcinoma patients</term>
<term>Apoptosis</term>
<term>Arsenic trioxide</term>
<term>Asian society</term>
<term>Assay</term>
<term>Attenuated salmonella</term>
<term>Attenuation value</term>
<term>Autophagy</term>
<term>Benign</term>
<term>Benign giant cell tumor</term>
<term>Better prognosis</term>
<term>Bevacizumab</term>
<term>Biomarker</term>
<term>Biomarkers</term>
<term>Biopsy</term>
<term>Biopsy specimens</term>
<term>Bregs</term>
<term>Cancer</term>
<term>Cancer cells</term>
<term>Cancer deaths</term>
<term>Carcinoma</term>
<term>Case report</term>
<term>Catenin</term>
<term>Cell death</term>
<term>Cell lines</term>
<term>Cell lung cancer</term>
<term>Cell proliferation</term>
<term>Chemoradiation</term>
<term>Chemoradiation therapy</term>
<term>Chemotherapy</term>
<term>China background</term>
<term>Cigarette smoke</term>
<term>Cipto mangunkusumo</term>
<term>Cisplatin</term>
<term>Cisplatin resistance</term>
<term>Clinical characteristics</term>
<term>Clinical features</term>
<term>Clinical practice</term>
<term>Copd</term>
<term>Cpfe</term>
<term>Cpfe patients</term>
<term>Cyfra</term>
<term>December</term>
<term>Diffuse consolidation</term>
<term>Disease control rate</term>
<term>Early diagnosis</term>
<term>Effusion</term>
<term>Egfr</term>
<term>Egfr mutation</term>
<term>Egfr mutation status</term>
<term>Egfr mutations</term>
<term>Elderly patients</term>
<term>Epidermal</term>
<term>Epidermal growth factor receptor</term>
<term>Epidermal growth factor receptor mutations</term>
<term>Erlotinib</term>
<term>Erlotinib treatment</term>
<term>Exon</term>
<term>Expiratory volume</term>
<term>Expression levels</term>
<term>Fudan</term>
<term>Fudan university</term>
<term>Gender</term>
<term>Graduate school</term>
<term>Healthy controls</term>
<term>High risk</term>
<term>Histological</term>
<term>Histological growth pattern</term>
<term>Histological pattern</term>
<term>Hong kong</term>
<term>Hong kong background</term>
<term>Hospital medan</term>
<term>Human lung adenocarcinoma</term>
<term>Iiib</term>
<term>Incidental thyroid nodules</term>
<term>Independent prognostic factor</term>
<term>Independent risk factor</term>
<term>Inhibitor</term>
<term>Initial antimicrobial agents</term>
<term>Internal medicine</term>
<term>Invasive mucinous</term>
<term>January</term>
<term>Japan background</term>
<term>Japan background lung cancer</term>
<term>Jilin</term>
<term>Jilin university</term>
<term>Kinase</term>
<term>Kyushu university</term>
<term>Laryngeal metastasis</term>
<term>Late complications</term>
<term>Lats2</term>
<term>Lats2 expression</term>
<term>Lesion</term>
<term>Lipid</term>
<term>Lobe</term>
<term>Lower lobe</term>
<term>Lung</term>
<term>Lung adenocarcinoma</term>
<term>Lung cancer</term>
<term>Lung cancer patients</term>
<term>Lung cancers</term>
<term>Lymphocyte</term>
<term>Lymphoma</term>
<term>Malaysia</term>
<term>Malaysian</term>
<term>Malaysian patients</term>
<term>Malignant</term>
<term>Malignant thyroid nodules</term>
<term>Malik</term>
<term>Medan</term>
<term>Median</term>
<term>Median survival time</term>
<term>Medical oncology</term>
<term>Medical sciences</term>
<term>Mesothelioma</term>
<term>Mesothelioma cell lines</term>
<term>Metastasis</term>
<term>Modality</term>
<term>Mrna</term>
<term>Mucinous</term>
<term>Multivariate</term>
<term>Multivariate analysis</term>
<term>Mutation</term>
<term>N1icd</term>
<term>Nagasaki</term>
<term>Nicotine</term>
<term>Nodule</term>
<term>Nonsmall</term>
<term>Notch1</term>
<term>Nsclc</term>
<term>Nsclc patients</term>
<term>Nude mice</term>
<term>Oncology</term>
<term>Other hand</term>
<term>Other patients</term>
<term>Overall survival</term>
<term>Pathway</term>
<term>Pemetrexed</term>
<term>Performance status</term>
<term>Peripheral thoracic lesions</term>
<term>Plasmid</term>
<term>Platinum doublet</term>
<term>Pleural effusion</term>
<term>Plk1</term>
<term>Plk1 gene</term>
<term>Poor lung function</term>
<term>Poor prognosis</term>
<term>Predictive factor</term>
<term>Primary lung cancer</term>
<term>Prognosis</term>
<term>Prognostic</term>
<term>Prognostic factors</term>
<term>Progression</term>
<term>Protein expression</term>
<term>Protein levels</term>
<term>Pulmonary lymphoid tissue lymphoma</term>
<term>Pulmonary medicine</term>
<term>Pulmonary metastases</term>
<term>Pulmonology</term>
<term>Rack1</term>
<term>Rbm5</term>
<term>Receptor</term>
<term>Respiratory disease</term>
<term>Respiratory failure</term>
<term>Respiratory medicine</term>
<term>Respirology</term>
<term>Response rate</term>
<term>Retrospective</term>
<term>Retrospective analysis</term>
<term>Retrospectively</term>
<term>Right axilla</term>
<term>Sclc</term>
<term>Sclc patients</term>
<term>Second hospital</term>
<term>Secondary lung cancer</term>
<term>Sirna</term>
<term>Small cell lung cancer patients</term>
<term>Smoker</term>
<term>Smoking history</term>
<term>Smoking status</term>
<term>Squamous</term>
<term>Squamous cell carcinoma</term>
<term>Squamous cell carcinoma patients</term>
<term>Stage iiib</term>
<term>Stage lung cancer</term>
<term>Stage lung cancer patients</term>
<term>Suppl</term>
<term>Suppressor</term>
<term>Thoracic</term>
<term>Thoracic surgery</term>
<term>Thymidylate synthase</term>
<term>Thyroid nodules</term>
<term>Toxicity</term>
<term>Transthoracic</term>
<term>Transthoracic biopsy</term>
<term>Tregs</term>
<term>Tumor growth</term>
<term>Tumor volume</term>
<term>Tumour</term>
<term>Twist1</term>
<term>Tyrosine kinase inhibitor</term>
<term>Upper lobe</term>
<term>Vimentin</term>
<term>Wang</term>
<term>Weight loss</term>
<term>Western blot</term>
<term>Xenograft</term>
<term>Xiangya hospital</term>
<term>Yonsei university college</term>
<term>Zhongshan</term>
<term>Zhongshan hospital</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<affiliations>
<list></list>
<tree></tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001382 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001382 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:FF252DE98D9599EA1F9CD4859BE5AF21F5D3CD0E
   |texte=   Lung Cancer
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021